An Alzheimer's blood test could also help scientists "more efficiently enroll participants in clinical trials, which will help us find treatments faster."

The new mouse model also holds promise for studying other neurological conditions such as Parkinson's disease, traumatic brain injury, and stroke.

75 percent of Alzheimer's disease patients are unlikely to benefit from a class of drugs that showed promise in animal studies, report researchers.

Intelligence and education may not protect you against Alzheimer's disease, but they could offer a protective "head start."

Doctors may one day diagnose Alzheimer's disease with a simple blood test. The new technology, called APEX, detects amyloid beta.

"There is no Goldilocks decade during which you can say, 'This is when I get my chance to short sleep.'"

A link between amyloid plaques and tau build-up in the brains of people with Alzheimer's disease could lead to a way to slow its progress.

New research reveals the connection between the antioxidant SOD1 and tau build-up in the spread of Alzheimer's disease.

Rapamycin is getting a lot of attention for its potential as an anti-aging drug. Now researchers have figured out exactly how it works.

Virtual reality (VR) can identify early Alzheimer’s disease more accurately than ‘gold standard’ cognitive tests currently in use, suggests new research from the University of Cambridge.